title: Radiofrequency ablation of unresectable primary liver cancer.
authors.affiliation: Technology Evaluation Center, Blue Cross and Blue Shield Association, Chicago, IL 60601-7680, USA.
authors.forename: Jerome
authors.initials: J
authors.lastname: Seidenfeld
authors.forename: Allan
authors.initials: A
authors.lastname: Korn
authors.forename: Naomi
authors.initials: N
authors.lastname: Aronson
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000628:therapy*; D017115:Catheter Ablation / Q000379:methods* / Q000592:standards; D003131:Combined Modality Therapy; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000188:drug therapy / Q000628:therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000431:Ethanol